ELS - VHD and Transcatheter Aortic Valve Replacement

Transcatheter Aortic Valve Replacement

ACCF Transcatheter Aortic Valve Replacement GUIDELINES App brought to you free of charge courtesy of Guideline Central. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/109740

Contents of this Issue

Navigation

Page 7 of 9

Treatment Table 1. Current Treatment Recommendations for Patients with Aortic Stenosis Treatment Indication Major Complications Surgical Aortic Valve Replacement ������ Symptomatic severe AS (I-B) ������ Severe AS undergoing CABG, aortic surgery or other valve surgery (I-C) ������ Symptomatic moderate AS undergoing CABG, aortic surgery or other valve surgery (IIa-C) ������ Asymptomatic severe AS with hypotensive response to exercise (IIb-C) ������ Asymptomatic extremely severe AS (AVA < 0.6 cm2, mean gradient > 50 mm Hg, or jet velocity > 5 m/s) (IIb-C) ������ Mortality (3%) ������ Stroke (2%) ������ Prolonged ventilation (11%) ������ Thromboembolism and bleeding ������ Prosthetic dysfunction ������ Perioperative complications are higher when surgical AVR is combined with CABG Transcatheter Aortic Valve Replacement ������ TAVR is recommended in patients with severe, symptomatic, calcific stenosis of a tricuspid aortic valve who have aortic and vascular anatomy suitable for TAVR and a predicted survival >12 months, and who have a prohibitive surgical risk as defined by an estimated 50% or greater risk of mortality or irreversible morbidity at 30 days or other factors such as frailty, prior radiation therapy, porcelain aorta, and severe hepatic or pulmonary disease. ������ TAVR is a reasonable alternative to surgical AVR in patients at high surgical risk (PARTNER Trial Criteria: STS ���8%a) ������ Mortality (3%-5%) ������ Stroke (6%-7%) ������ Access complications (17%) ������ Pacemaker insertion ������ 2%-9% (Sapien) ������ 19%-43% (CoreValveb) ������ Bleeding ������ Prosthetic dysfunction ������ Paravalvular AR ������ Acute kidney injury ������ Other ������ Coronary occlusion ������ Valve embolization ������ Aortic rupture Balloon Aortic Valvuloplasty ������ Reasonable for palliation in adult patients with AS in whom surgical AVR cannot be performed because of serious comorbid conditions (IIb-C) ������ Bridge to surgical AVR (if patient is poor surgical candidate) (IIb-C) ������ Mortality ������ Stroke ������ Access complications ������ Restenosis

Articles in this issue

Archives of this issue

view archives of ELS - VHD and Transcatheter Aortic Valve Replacement - Transcatheter Aortic Valve Replacement